Gastroenterology Exam Is a Failure for ChatGPT Bot.

Published Date: 27 May 2023

The AI language-processing model did not pass a self-assessment test with a minimum passing grade of 70% and is not advised for use in medical education.

Read Full News

Latest News

Boehringer Ingelheim Launches AI Centre for Pharma Research in London

German drugmaker Boehringer Ingelheim is launching a centre for artificial intelligence and machine learning ⁠in London, it said on Monday, as it seeks to expand its AI...

How Much Do Long Wait Times Cost Canadian Patients?

Long wait times for surgery and medical treatment cost Canadians over $4.2 billion in lost wages and productivity in 2025.

Virtual Physiotherapy Shows Promise for Chronic Cough

A single 1-hour virtual group physiotherapy intervention for chronic cough achieves high uptake and reduces cough severity and frequency.

Germans Trust ‘Dr AI’ More Than Doctors Who Use It

Nearly half of Germans consult AI before seeing a physician, and some rate chatbot advice as equal to a medical second opinion.

Neurology Clinics are Adopted by Genetic Therapies.

There are new treatments for genetic neuromuscular diseases in the works, which will present challenges for neurologists as well as opportunities for patients.

Thermo Fisher Issues a Warning About the Squeeze in Biotech Funding.

Indicating that biotechs' lack of interest in using Thermo Fisher Scientific's services to create treatments and vaccines may last into the following year, the company released a statement on Wednesday.

Todays Updates

EMA Backs Breast Cancer SERD After FDA No Vote

The recommendation follows phase 3 data showing longer progression-free survival when patients switched to camizestrant plus a CDK4/6 inhibitor.

Datopotamab Deruxtecan Earns New Breast Cancer Indication

The antibody drug conjugate was approved by the FDA for certain patients with triple-negative breast cancer.

Todays Updates

EMA Backs Breast Cancer SERD After FDA No Vote

The recommendation follows phase 3 data showing longer progression-free survival when patients switched to camizestrant plus a CDK4/6 inhibitor.

Datopotamab Deruxtecan Earns New Breast Cancer Indication

The antibody drug conjugate was approved by the FDA for certain patients with triple-negative breast cancer.

Latest News

German drugmaker Boehringer Ingelheim is launching a centre for artificial intelligence and machine learning ⁠in London, it said on Monday, as it seeks to expand its AI...

Long wait times for surgery and medical treatment cost Canadians over $4.2 billion in lost wages and productivity in 2025.

A single 1-hour virtual group physiotherapy intervention for chronic cough achieves high uptake and reduces cough severity and frequency.

Nearly half of Germans consult AI before seeing a physician, and some rate chatbot advice as equal to a medical second opinion.

There are new treatments for genetic neuromuscular diseases in the works, which will present challenges for neurologists as well as opportunities for patients.

Indicating that biotechs' lack of interest in using Thermo Fisher Scientific's services to create treatments and vaccines may last into the following year, the company released a statement on Wednesday.

News All Time

WHO Issues Warning Against Misinformation When Using AI in Healthcare.

On Tuesday, the World Health Organization warned against using AI in public healthcare because the data it uses to make decisions may be biased or misapplied.

US Jury Rules in Favor of Natera in Cancer-Detection Patent Case.

Monday, a federal jury in Delaware was persuaded to award genetic testing company Natera Inc. $19.3 million in damages from Invitae Corp.'s ArcherDX for infringing patents pertaining to cancer detection.

Changes in Hypertrophic Cardiomyopathy Risk Stratification?

Data show that compared to 24-hour monitoring, extended ECG monitoring detects a higher incidence of clinically relevant arrhythmias.

New Trials in Breast Cancer: Could Your Patient Benefit?

Perhaps one of your patients qualifies to participate in a clinical trial that is currently looking for breast cancer patients.

The Musk Animal Testing Panel Is Riddled With Possibilities.

A board overseeing animal research has been staffed by insiders from Elon Musk's brain-implant business who could profit financially as the company advances.

Drugmakers increase their research spending and look for deals.

As the larger players in the sector look for new sources of long-term revenue, drugmakers announced on Thursday that they are open to acquisitions and that their R&D spending has increased.

EU Law Reform Could Lead to a Shift in Investments: GSK.

The European Union's pharmaceutical industry is governed by new laws, which the British pharmaceutical company GSK warned on Wednesday run the risk of driving businesses to innovate and invest elsewhere.

Proposed Drug Law Reforms Published by the EU.

On Wednesday, Brussels released a long-awaited draft of its proposed overhaul of the laws governing the pharmaceutical industry in the European Union, setting off a dispute with drugmakers who threaten to invest and innovate elsewhere.

BioNTech and DualityBio will develop cancer drugs worth more than $1.5 billion

German company BioNTech said on Monday that it has signed an agreement with Chinese biotech company DualityBio to jointly develop and commercialize two cancer drug candidates.

Musk's brain transplant company seeks human collaboration

Elon Musk's neuroimplantation company Neuralink has reached one of the largest neurosurgical centers in the country capable of testing partners as it plans to test human devices if the regulator.

FDA moves to quickly approve gene therapy

The FDA is making important changes to gene therapy development, including encouraging the use of biomarkers that help recommend treatments for serious conditions, FDA officials said.

AI pab kwv yees ulcerative colitis remission/activity, relapse.

AI tools can distinguish between functional and histological clearance and predict the severity of ulcerative colitis biopsies, and can play a role in clinical trials and routine practice.

The fall of SVB casts a shadow over the beginnings of American biotechnology

The Silicon Valley banking meltdown will leave biotech start-ups with different funding options, investors and analysts said Monday.

SVB shock could have chilling effect on UK biotech sector

HSBC's bailout of the UK branch of the Silicon Valley bank has saved Britain's main biotech sector from collapse, but funding a sector the government sees as essential for the growth of the future economy could be affected, according to industry executives.

The risk of stent infection is low but can be reported

A review of stent coronary artery disease has led researchers to question whether these events are underreported.

Sleep Apnea Control Persists for Some After Stopping Device

Standard treatment for obstructive sleep apnea has long relied on continuous positive airway pressure machines, but new research suggests that for some, the issue is simply a matter of body position.

Recommended News For You

Shorter, less intense regimen still effective for HPV-linked throat cancer, study shows

Adopted cancer cells and the effects of their presence.

Combo Therapy Boosts Early CML Response but Not Long Term

Pickleball program boosts health and wellness for cancer survivors, study finds

Sustained reduction found in prostate cancer mortality with prostate-specific antigen screening

"We Caught It Early": Advantage or Disadvantage?

From 40 to 74, the US Preventive Services Task Force advises every two years for screening mammography.

Recommended Articles For You

Screening Efficacy, Molecular Precision, and Therapeutic Revolutions in Lung Cancer 2025 

Everything You Need To Know About Melanoma Choroid: Causes, Symptoms, and Treatment 

Uncovering the Hidden Picture: Using Ultrasound to Diagnose Breast Cancer 

The Significance of APTT Blood Test Results for Detecting Coagulation Disorders 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Non-Factor Therapies in Hemophilia: Cutting-Edge Approaches to Individualize Care

2.

FDA approves Blenrep for relapsed or refractory multiple myeloma

3.

X-ray and radar technology combined to reduce cancer screening risks

4.

Extended Maintenance with Imatinib Enhances Disease-Free Survival in High-Risk GIST.

5.

Researchers discuss HER2-low and HER2-zero in breast cancer

1.

Understanding Mesenteric Masses: Symptoms, Diagnosis, and Treatment Options

2.

Liposomal Doxorubicin and Mitomycin in Modern Cancer Treatment

3.

The New Era of Oncology: Key Updates and Clinical Insights

4.

HIPEC in Platinum-Sensitive Ovarian Cancer: A Promising Yet Controversial Option

5.

Theranostics and Radioligand Therapy: Precision Cancer Care with Targeted Radionuclides

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial

2.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part I

3.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

4.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II

5.

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot